| Literature DB >> 33417208 |
David Cheillan1,2.
Abstract
Zellweger syndrome disorders (ZSD) is the principal group of peroxisomal disorders characterized by a defect of peroxisome biogenesis due to mutations in one of the 13 PEX genes. The clinical spectrum is very large with a continuum from antenatal forms to adult presentation. Whereas biochemical profile in body fluids is classically used for their diagnosis, the revolution of high-throughput sequencing has extended the knowledge about these disorders. The aim of this review is to offer a large panorama on molecular basis, clinical presentation and treatment of ZSD, and to update the diagnosis strategy of these disorders in the era of next-generation sequencing (NGS).Entities:
Keywords: Next-generation sequencing (NGS); PEX genes; Peroxisome; Peroxisome biogenesis disorder (PBD); Prenatal diagnosis; Very-long-chain fatty acids (VLCFAs); Zellweger syndrome disorder (ZSD)
Mesh:
Year: 2020 PMID: 33417208 DOI: 10.1007/978-3-030-60204-8_6
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622